| Application number | Title of the application | Filing Date | Status |
|---|
| 07/685819 | INTERLEUKIN-1 INHIBITORS | Apr 14, 1991 | Abandoned |
| 07/678828 | HEPATITIS A VIRUS VACCINE | Apr 2, 1991 | Abandoned |
| 07/669528 | RECOMBINANT HYBRID PORIN EPITOPES | Mar 13, 1991 | Abandoned |
Array
(
[id] => 2781969
[patent_doc_number] => 05164315
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1992-11-17
[patent_title] => 'Basic protein phospholiphase A2'
[patent_app_type] => 1
[patent_app_number] => 7/653133
[patent_app_country] => US
[patent_app_date] => 1991-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 4010
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/164/05164315.pdf
[firstpage_image] =>[orig_patent_app_number] => 653133
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/653133 | Basic protein phospholiphase A2 | Feb 10, 1991 | Issued |
Array
(
[id] => 2957412
[patent_doc_number] => 05198344
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-03-30
[patent_title] => 'DNA sequence that encodes the multidrug resistance gene'
[patent_app_type] => 1
[patent_app_number] => 7/652311
[patent_app_country] => US
[patent_app_date] => 1991-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 24
[patent_no_of_words] => 9032
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/198/05198344.pdf
[firstpage_image] =>[orig_patent_app_number] => 652311
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/652311 | DNA sequence that encodes the multidrug resistance gene | Feb 5, 1991 | Issued |
Array
(
[id] => 2985281
[patent_doc_number] => 05212070
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-05-18
[patent_title] => 'Secretory signal selection vectors for extracellular protein synthesis in Bacilli'
[patent_app_type] => 1
[patent_app_number] => 7/627028
[patent_app_country] => US
[patent_app_date] => 1990-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 6
[patent_no_of_words] => 11262
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/212/05212070.pdf
[firstpage_image] =>[orig_patent_app_number] => 627028
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/627028 | Secretory signal selection vectors for extracellular protein synthesis in Bacilli | Dec 12, 1990 | Issued |
| 07/627876 | VARIANTS OF HIRUDIN, THEIR USE AND THEIR PREPARATION | Dec 12, 1990 | Abandoned |
| 07/623256 | FUNCTIONAL DNA BLOCK AND PLASMID CODING FOR HIRUDIN, TRANSFORMED YEAST, METHOD FOR PREPARING HIRUDIN, HIRUDIN OBTAINED AND ITS PHARMACEUTICAL USE | Dec 4, 1990 | Abandoned |
| 07/615211 | MAREK'S DISEASE VIRUS VACCINE | Nov 15, 1990 | Abandoned |
Array
(
[id] => 2804330
[patent_doc_number] => 05156959
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1992-10-20
[patent_title] => 'Method to export gene products to the growth medium of gram negative bacteria'
[patent_app_type] => 1
[patent_app_number] => 7/602935
[patent_app_country] => US
[patent_app_date] => 1990-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 9
[patent_no_of_words] => 7095
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/156/05156959.pdf
[firstpage_image] =>[orig_patent_app_number] => 602935
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/602935 | Method to export gene products to the growth medium of gram negative bacteria | Oct 23, 1990 | Issued |
Array
(
[id] => 2904277
[patent_doc_number] => 05215892
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-06-01
[patent_title] => 'C/EBP2 gene and recombinant C/EBP2'
[patent_app_type] => 1
[patent_app_number] => 7/601094
[patent_app_country] => US
[patent_app_date] => 1990-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10307
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/215/05215892.pdf
[firstpage_image] =>[orig_patent_app_number] => 601094
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/601094 | C/EBP2 gene and recombinant C/EBP2 | Oct 21, 1990 | Issued |
Array
(
[id] => 2985243
[patent_doc_number] => 05212068
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-05-18
[patent_title] => 'Human pancreatic elastase'
[patent_app_type] => 1
[patent_app_number] => 7/602190
[patent_app_country] => US
[patent_app_date] => 1990-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 22610
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/212/05212068.pdf
[firstpage_image] =>[orig_patent_app_number] => 602190
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/602190 | Human pancreatic elastase | Oct 21, 1990 | Issued |
Array
(
[id] => 2838867
[patent_doc_number] => 05171684
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1992-12-15
[patent_title] => 'Bioconversions catalyzed by the toluene monooxygenase of Pseudomanas mendocina KR-1'
[patent_app_type] => 1
[patent_app_number] => 7/590374
[patent_app_country] => US
[patent_app_date] => 1990-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 14133
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/171/05171684.pdf
[firstpage_image] =>[orig_patent_app_number] => 590374
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/590374 | Bioconversions catalyzed by the toluene monooxygenase of Pseudomanas mendocina KR-1 | Sep 27, 1990 | Issued |
Array
(
[id] => 3480054
[patent_doc_number] => 05457038
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-10-10
[patent_title] => 'Natural killer stimulatory factor'
[patent_app_type] => 1
[patent_app_number] => 7/584941
[patent_app_country] => US
[patent_app_date] => 1990-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13412
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/457/05457038.pdf
[firstpage_image] =>[orig_patent_app_number] => 584941
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/584941 | Natural killer stimulatory factor | Sep 17, 1990 | Issued |
| 07/572284 | PURIFICATION AND CHARACTERIZATION OF CYTOTOXIC LYMPHOCYTE MATURATION FACTOR AND MONOCLONAL ANTIBODIES THERETO | Aug 26, 1990 | Abandoned |
| 07/557983 | NOVEL PLASMIDS AND TRANSFORMANTS | Jul 25, 1990 | Abandoned |
Array
(
[id] => 2784042
[patent_doc_number] => 05130250
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1992-07-14
[patent_title] => 'Molecular cloning and expression of neutral protease genes'
[patent_app_type] => 1
[patent_app_number] => 7/540035
[patent_app_country] => US
[patent_app_date] => 1990-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 3
[patent_no_of_words] => 5188
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/130/05130250.pdf
[firstpage_image] =>[orig_patent_app_number] => 540035
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/540035 | Molecular cloning and expression of neutral protease genes | Jul 11, 1990 | Issued |
Array
(
[id] => 2842637
[patent_doc_number] => 05110587
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1992-05-05
[patent_title] => 'Immunogenic composition comprising synthetically modified vaccinia virus'
[patent_app_type] => 1
[patent_app_number] => 7/537882
[patent_app_country] => US
[patent_app_date] => 1990-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 20
[patent_no_of_words] => 33721
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/110/05110587.pdf
[firstpage_image] =>[orig_patent_app_number] => 537882
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/537882 | Immunogenic composition comprising synthetically modified vaccinia virus | Jun 13, 1990 | Issued |
Array
(
[id] => 2859246
[patent_doc_number] => 05166318
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1992-11-24
[patent_title] => 'Polypeptide having thrombin inhibiting activity'
[patent_app_type] => 1
[patent_app_number] => 7/531403
[patent_app_country] => US
[patent_app_date] => 1990-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11105
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/166/05166318.pdf
[firstpage_image] =>[orig_patent_app_number] => 531403
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/531403 | Polypeptide having thrombin inhibiting activity | Jun 3, 1990 | Issued |
| 07/529758 | VECTORS FOR THE EXPRESSION AND SECRETION OF HIRUDIN BY TRANSFORMED YEASTS | May 28, 1990 | Abandoned |